Sabal Combination 9243 (sabal combination) NDC 63083-9243

NDC codes

FDA NDC Directory

Product NDC (as listed)63083-9243Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63083-9243Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
63083-9243-1	63083924301	29.5 mL in 1 BOTTLE, DROPPER (63083-9243-1)Marketed from Aug 15, 1985

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sabal Combination 9243Suffix: 9243
Generic name (nonproprietary): sabal combination
Active ingredients: Saw palmetto — 1 [hp_X]/29.5mLChimaphila umbellata whole — 10 [hp_X]/29.5mLCalcium sulfide — 10 [hp_X]/29.5mL
Dosage form: Liquid
Route: Oral
Labeler: Professional Complementary Health Formulas
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Aug 15, 1984
Listing expires: Dec 31, 2027
Identifiers: Product ID 63083-9243_39c2c2bb-c533-473a-b7a9-02a678893cf3SPL ID 39c2c2bb-c533-473a-b7a9-02a678893cf3SPL set ID 011790c2-5087-41da-9df7-3fd754b6c73cUNII J7WWH9M8QS, WCK21A9W9J, 1MBW07J51Q

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N463083924301 followed by a unit qualifier and the quantity

Package 63083-9243-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 8, 2026.

Indications (excerpt from the label)

INDICATIONS For the temporary relief of mild abdominal pain, diarrhea, constipation, or hemorrhoids.*

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)